Genmab A (GMAB) Change in Acquisitions & Divestments (2020 - 2025)

Genmab A (GMAB) has reported Change in Acquisitions & Divestments for 5 consecutive years, with $930.0 million the latest figure, recorded in Q3 2025.

• For the quarter ending Q3 2025, Change in Acquisitions & Divestments fell 32.8% year-over-year to $930.0 million; the trailing twelve-month figure through Sep 2025 stood at $3.2 billion (up 190.54% YoY), and the FY2025 full-year result was $2.6 billion, up 60.27% from the prior year.
• Change in Acquisitions & Divestments grew to $930.0 million in Q3 2025 per GMAB's latest filing, from $595.0 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $3.0 billion in Q1 2023 and bottomed at -$6.4 billion in Q4 2023.
• Historically, Change in Acquisitions & Divestments has averaged $446.8 million across 4 years, with a median of $930.0 million in 2025.
• The sharpest annual moves came in 2024 and 2025: Change in Acquisitions & Divestments slumped 84.6% in 2024, then sank 32.8% in 2025.
• Over 4 years, Change in Acquisitions & Divestments stood at $2.8 billion in 2021, then sank by 331.74% to -$6.4 billion in 2023, then soared by 121.57% to $1.4 billion in 2024, then slumped by 32.8% to $930.0 million in 2025.
• According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $930.0 million, $595.0 million, and $259.0 million for Q3 2025, Q2 2025, and Q1 2025 respectively.